BioMarin Pharmaceutical Inc. buy Morgan Stanley
Start price
01.08.23
/
50%
€79.72
Target price
01.08.24
€113.91
Performance (%)
-3.59%
End price
02.08.24
€76.86
Summary
This prediction ended on 02.08.24 with a price of €76.86. With a performance of -3.59%, the BUY prediction by Morgan_Stanley finished with a loss. Morgan_Stanley has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | -0.950% | -0.950% | -4.505% |
| iShares Core DAX® | -3.935% | -2.628% | 10.013% |
| iShares Nasdaq 100 | -3.608% | -9.283% | 20.668% |
| iShares Nikkei 225® | -4.513% | -6.951% | 5.241% |
| iShares S&P 500 | -2.607% | -4.402% | 20.177% |
Comments by Morgan_Stanley for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at Morgan Stanley from $129.00 to $125.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.64
26.04.24
26.04.24
€104.69
26.04.25
26.04.25
2.01%
02.08.24
02.08.24
